MacroGenics, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-74.6M | $-67.0M | $-9.1M | $-119.8M | $-202.1M | $-129.7M | $-151.8M | $-171.5M |
| Depreciation & Amortization | $7.2M | $7.5M | $9.6M | $11.9M | $11.3M | $12.0M | $12.3M | $9.2M |
| Depreciation | $7.2M | $7.5M | $9.6M | $11.9M | $11.3M | $12.0M | $12.3M | $9.2M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $14.3M | $29.4M | $18.4M | $20.4M | $23.1M | $20.7M | $19.6M | $16.5M |
| Net Cash from Operating Activities | $-81.0M | $-68.4M | $-78.2M | $-87.0M | $-143.8M | $-111.9M | $-134.3M | $-153.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.9M | $3.7M | $1.8M | $3.6M | $6.2M | $5.9M | $4.3M | $25.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-114.1M | $149.3M | $-80.1M | $70.7M | $-36.6M | $-7.8M | $-79.4M | $56.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $69.5M | $960.0K | $150.4M | $1.7M | $122.8M | $174.3M | $120.0M | $105.0M |
| Net Change in Cash | $-125.6M | $81.9M | $-7.9M | $-14.6M | $-57.7M | $54.7M | $-93.7M | $8.4M |
| Free Cash Flow | $-83.0M | $-72.1M | $-80.0M | $-90.6M | $-150.0M | $-117.8M | $-138.6M | $-178.2M |